Acute bronchitis due to Hemophilus influenzae
ICD-10 J20.1 is a billable code used to indicate a diagnosis of acute bronchitis due to hemophilus influenzae.
Acute bronchitis due to Hemophilus influenzae is characterized by the inflammation of the bronchial tubes, which leads to cough, sputum production, and difficulty breathing. This condition typically arises following a viral upper respiratory infection but can be exacerbated by bacterial pathogens such as Hemophilus influenzae. The anatomy involved includes the tracheobronchial tree, where the bronchial tubes become inflamed and produce excess mucus. Clinically, patients may present with symptoms such as a persistent cough, wheezing, chest discomfort, and fatigue. Disease progression can vary, with some patients recovering within a few weeks while others may experience prolonged symptoms or complications such as pneumonia. Diagnostic considerations include a thorough history and physical examination, chest auscultation, and possibly sputum cultures to identify the causative organism. Radiological imaging is not typically required unless complications are suspected. Accurate diagnosis is crucial for appropriate management and treatment, which may include bronchodilators, corticosteroids, and antibiotics if a bacterial infection is confirmed.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J20.1 specifically covers acute bronchitis caused by Hemophilus influenzae. It is important to differentiate this from other types of bronchitis that may be viral or caused by other bacteria.
J20.1 should be used when the clinical evidence supports a diagnosis of acute bronchitis specifically due to Hemophilus influenzae, as opposed to other pathogens or non-infectious causes.
Documentation should include a clear clinical history, physical examination findings, results from any diagnostic tests (e.g., sputum culture), and treatment plans that indicate the presence of Hemophilus influenzae.
